Alerts will be sent to your verified email
Verify Email
WOCKPHARMA
|
Wockhardt
|
Laxmi Organic Inds.
|
Suven Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Domestic Sales Growth - YoY
|
10.6 % | n/a | n/a |
|
R&D as a % of Total Sales
|
4.2 % | n/a | 0.6 % |
|
Financials
|
|||
|
5 yr Average ROE
|
-2.51 % | 14.71 % | 28.03 % |
|
5yr average Equity Multiplier
|
2.4 | 2.0 | 1.35 |
|
5yr Average Asset Turnover Ratio
|
0.4 | 1.29 | 0.61 |
|
5yr Avg Net Profit Margin
|
-2.24 % | 5.83 % | 33.58 % |
|
Price to Book
|
2.84 | 4.78 | 8.65 |
|
P/E
|
0.0 | 69.41 | 45.16 |
|
5yr Avg Cash Conversion Cycle
|
-159.51 Days | 8.54 Days | 50.89 Days |
|
Inventory Days
|
72.12 Days | 37.92 Days | 88.08 Days |
|
Days Receivable
|
73.25 Days | 80.83 Days | 47.25 Days |
|
Days Payable
|
241.3 Days | 113.09 Days | 110.61 Days |
|
5yr Average Interest Coverage Ratio
|
-0.73 | 10.34 | 48.24 |
|
5yr Avg ROCE
|
-1.75 % | 17.71 % | 33.9 % |
|
5yr Avg Operating Profit Margin
|
5.17 % | 10.53 % | 47.3 % |
|
5 yr average Debt to Equity
|
0.84 | 0.26 | 0.12 |
|
5yr CAGR Net Profit
|
23.51 % | 11.47 % | 30.36 % |
|
5yr Average Return on Assets
|
-1.05 % | 7.44 % | 20.69 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
51.6 % | 69.72 % | 50.1 % |
|
Share Pledged by Promoters
|
52.9 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-20.52 % | -3.2 % | -9.9 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
3.1 % | 0.22 % | 10.96 % |
|
Wockhardt
|
Laxmi Organic Inds.
|
Suven Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|
